This is a routine insider transaction following option exercise; monitor for actual execution via Form 4 filing. Given the officer status, follow-through could signal confidence or simply portfolio management — context from future filings will clarify.
Price Chart
Executive Summary
Jennifer Jarrett, an officer of Arcus Biosciences, filed a Form 144 to notify intent to sell 70,000 shares of common stock, valued at approximately $1.58 million based on current market prices. The shares were acquired via stock option exercise and the sale is planned on the NYSE.
Key Facts
- Reporting person: Jennifer Jarrett, Officer
- Number of shares intended for sale: 70,000
- Approximate value of shares: $1,579,592 (based on $22.56/share)
- Shares acquired via: Stock option exercise
- Issuer: Arcus Biosciences, Inc. (RCUS)
- Filing date: April 8, 2026
- Planned transaction date: April 8, 2026
- Broker: Morgan Stanley Smith Barney LLC
Financial Impact
70,000 shares worth ~$1.58 million, representing a small fraction of the company's $2.8B market cap
Risk Factors
- Potential downward pressure on stock if sale executes near-term
- Perception of insider selling ahead of uncertain catalysts, though no such timing is indicated here
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003313 |
| Document: 0001950047-26-003313-index.html | 0001950047-26-003313 |
| Document: 0001950047-26-003313.txt | 0001950047-26-003313 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 9, 2026 12w ago | 144 | $28.92 $28.62 | ▼ −1.04% | ▼ −3.46% | $24.27 (−16.08%) |
Apr 21, 2026 23w ago | DEFA14A | $26.62 $22.75 | ▼ −14.54% | ▼ −17.70% | $24.27 (−8.83%) |
Apr 20, 2026 23w ago | 8-K | $22.74 $23.40 | ▼ −2.90% | ▲ +1.30% | $24.27 (−6.73%) |
Apr 8, 2026 25w ago | 144 | $23.28 $26.00 | ▲ +11.68% | ▲ +4.12% | $24.27 (+4.25%) |
Feb 25, 2026 31w ago | 8-K | $20.27 $21.46 | ▲ +5.87% | ▲ +11.11% | $24.27 (+19.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access